P
Peter Aspelin
Researcher at Karolinska Institutet
Publications - 176
Citations - 11786
Peter Aspelin is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Magnetic resonance imaging & Contrast medium. The author has an hindex of 39, co-authored 173 publications receiving 10434 citations. Previous affiliations of Peter Aspelin include Karolinska University Hospital & Harvard University.
Papers
More filters
Journal ArticleDOI
Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury
John A. Kellum,Norbert Lameire,Peter Aspelin,Rashad S. Barsoum,Emmanuel A. Burdmann,Stuart L. Goldstein,Charles A. Herzog,Michael Joannidis,Andreas Kribben,Andrew S. Levey,Alison M. MacLeod,Ravindra L. Mehta,Patrick T. Murray,Saraladevi Naicker,Steven M. Opal,Franz Schaefer,Miet Schetz,Shigehiko Uchino +17 more
Journal ArticleDOI
Nephrotoxic effects in high-risk patients undergoing angiography
Peter Aspelin,Pierre Aubry,Sven-Göran Fransson,Ruth H. Strasser,Roland Willenbrock,Knut Joachim Berg +5 more
TL;DR: Nephropathy induced by contrast medium may be less likely to develop in high-risk patients when iodixanol is used rather than a low-osmolar, nonionic contrast medium.
Journal ArticleDOI
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Fulvio Stacul,Aart J. van der Molen,Peter Reimer,Judith A. W. Webb,Henrik S. Thomsen,Henrik S. Thomsen,Sameh K. Morcos,Torsten Almén,Peter Aspelin,Marie-France Bellin,Olivier Clément,Gertraud Heinz-Peer +11 more
TL;DR: The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced nephropathy (CIN) with updated topics covered.
Journal ArticleDOI
Contrast-induced nephropathy: a clinical and evidence-based approach.
TL;DR: This review focuses on 4 major concerns of CIN relevant in clinical practice: what is the evidence that CIN is a clinically relevant and a dangerous condition for the patient, is there a difference in CIN rate among different contrast media, and how is that related to the physicochemical properties of different available contrast media?
Journal ArticleDOI
Diffusion-weighted magnetic resonance imaging of pancreas tumours.
TL;DR: DWI has a similar accuracy to MRI-c in diagnosis of pancreas cancer and apparent diffusion coefficient (ADC) values of lesions were significantly lower than those of benign lesions.